Treatment Registry
TR-0583 ActiveRecorded September 2026

Compounded tirzepatide

Sold by Fifty 410 · every compounded tirzepatide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

Recorded initial charges

Initial payment · 3-month plan

$399

Monthly equivalent

$133

initial payment (3-month medication term), including required fees on record. The monthly equivalent is not a monthly bill. It combines the advertised medication rate with any recorded monthly membership and excludes one-time and annual fees. Renewal charges are not established by that figure. Some fee details are unverified or unpublished; this sum does not establish the full amount payable.

Medication · Starter Program, 3-month · recorded upfront charge for 3 months$399

Added from the figures recorded below.

Price

TermPer monthCharged today
Starter Program, 3-month

“Starter Program Tirzepatide $133 /month $399 total”

Per month$133Charged today$399
Mid Dose Program, 3-month

“Mid Dose Program $166 /month $499 total”

Per month$166Charged today$499
High Dose Program, 3-month

“High Dose Program $183 /month $549 total”

Per month$183Charged today$549
Price sources
Visit Fifty 410

We earn nothing from this link. It opens Fifty 410's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

PrescriberBoth
CancellationOnce compounding begins, your medication is prepared to your prescribed specifications. This patient-specific preparation is why routine cancellations and refunds are not available after the compounding process starts.

Not yet checked: pharmacy, states, membership and consult fee.

Recorded from fifty410.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2026 — Explicitly no membership fee: 'There is no membership fee' and 'When am I charged? Only if a provider issues a prescription... There is no membership fee.' Both products are described only as 'administered by subcutaneous injection' without ever specifying vial vs. pen, so form is not-disclosed rather than assumed.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0583
Medication category
compounded tirzepatide
Readings
1

Related records

Other records from Fifty 410

All Fifty 410 programs and terms

Compounded tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 374 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Fifty 410 — compounded tirzepatide (TR-0583). Last verified September 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0583

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.